Assay to Measure Beta Blocker Adherence

Stopped early

Conditions studied: Congestive Heart Failure, Medication Adherence

In brief

This study will assess the feasibility and efficacy of using serum assay developed by Quest Diagnostics to detect the presence of beta blockers, specifically carvedilol and metoprolol succinate, in patients with heart failure.

Key facts

Study ID

NCT05251974

Run by

Summa Health System

People needed

27

Starts

2022-03-02

Expected to finish

2023-11-15

Last updated by the study team

2023-11-22

Who can join

Age: 18 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18-89
• Admitted for primary diagnosis of heart failure with reduced ejection fraction
• Prescribed carvedilol or metoprolol succinate for beta blocker therapy
• Will be following up at 95 Arch St. Clinic

You may not qualify if…

• Under age 18/over age 89
• Patients that plan to follow up somewhere other than the 95 Arch St. Clinic
• Patients with prior heart transplant or a left ventricular assist device
• Patient is unable to provide consent.

Where it is running

• Summa Health System — Akron, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.